annie
Lv1
50 积分
2023-04-18 加入
-
Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis
2天前
已完结
-
Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung Cancer
2天前
已完结
-
Perioperative Nivolumab in Resectable Lung Cancer
3天前
已完结
-
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
19天前
已完结
-
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
25天前
已完结
-
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
27天前
已完结
-
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
1个月前
已完结
-
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
1个月前
已完结
-
Use of a Personalized Multimedia Education Platform Improves Preoperative Teaching for Lung Cancer Patients
1个月前
已完结
-
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
1个月前
已完结